The store will not work correctly when cookies are disabled.
7-({3-[(dimethylamino)methyl]benzyl}oxy)-4-(hydroxymethyl)-2H-chromen-2-one
ID: ALA4539578
PubChem CID: 155549562
Max Phase: Preclinical
Molecular Formula: C20H21NO4
Molecular Weight: 339.39
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CN(C)Cc1cccc(COc2ccc3c(CO)cc(=O)oc3c2)c1
Standard InChI: InChI=1S/C20H21NO4/c1-21(2)11-14-4-3-5-15(8-14)13-24-17-6-7-18-16(12-22)9-20(23)25-19(18)10-17/h3-10,22H,11-13H2,1-2H3
Standard InChI Key: YVWBNPXKOWYLDZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
35.3648 -3.7021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3637 -4.5257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0758 -4.9388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7896 -4.5253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7868 -3.6985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0740 -3.2932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4930 -3.2872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2063 -3.6932 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.9166 -3.2819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6284 -3.6912 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6172 -2.0486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9104 -2.4656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3356 -2.4585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3352 -3.2767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0402 -3.6819 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
41.7502 -3.2774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.7506 -2.4592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0411 -2.0454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.4613 -3.6874 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.6529 -3.2937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6527 -2.4723 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.9407 -2.0598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3644 -2.0594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0404 -1.2241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.7518 -0.8107 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 14 1 0
13 11 1 0
11 12 2 0
12 9 1 0
13 14 2 0
13 18 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 2 0
16 19 2 0
1 20 1 0
20 21 1 0
21 22 1 0
21 23 1 0
18 24 1 0
24 25 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 339.39 | Molecular Weight (Monoisotopic): 339.1471 | AlogP: 2.93 | #Rotatable Bonds: 6 |
Polar Surface Area: 62.91 | Molecular Species: BASE | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 8.79 | CX LogP: 2.31 | CX LogD: 0.90 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.70 | Np Likeness Score: -0.45 |
References
1. Pisani L, Iacobazzi RM, Catto M, Rullo M, Farina R, Denora N, Cellamare S, Altomare CD.. (2019) Investigating alkyl nitrates as nitric oxide releasing precursors of multitarget acetylcholinesterase-monoamine oxidase B inhibitors., 161 [PMID:30366255] [10.1016/j.ejmech.2018.10.016] |